StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
15
Publishing Date
2023 - 10 - 31
1
2023 - 10 - 18
1
2023 - 01 - 18
1
2022 - 12 - 07
1
2022 - 08 - 18
1
2022 - 08 - 17
1
2022 - 08 - 12
1
2022 - 07 - 26
1
2022 - 04 - 19
1
2022 - 02 - 03
1
2022 - 01 - 12
1
2021 - 12 - 16
1
2021 - 11 - 15
1
2021 - 11 - 03
1
2021 - 10 - 29
1
Sector
Health technology
15
Tags
Application
2
Approval
10
Approved
4
Australia
1
Biocapital
4
Biotechnology
3
Canada
1
Covid
5
Covid-19
13
Drug
2
Food
1
Grant
1
Granted
3
Japan
2
License
1
N/a
6
New drug
1
Nuvaxovid
2
Nvx-cov2373
1
Prototype
1
Regulatory
1
Research
1
Submission
2
Vaccine
14
Entities
Abbott laboratories
61
Abbvie inc.
58
Adc therapeutics sa
20
Adma biologics inc
18
Agios pharmaceuticals, inc.
12
Alnylam pharmaceuticals, inc.
13
Amgen inc.
31
Amneal pharmaceuticals, inc.
17
Ani pharmaceuticals, inc.
19
Arrival
24
Astrazeneca plc
19
Aveo pharmaceuticals, inc.
22
Bausch health companies inc.
11
Beigene, ltd.
34
Biocryst pharmaceuticals, inc.
16
Biogen inc.
26
Blueprint medicines corporation
24
Bristol-myers squibb company
60
Calliditas therapeutics ab
12
Clovis oncology, inc.
20
Cns pharmaceuticals, inc.
13
Eli lilly and company
79
Epizyme, inc.
19
Exelixis, inc.
14
Fast acquisition corp.
13
Franchise group, inc.
16
Gilead sciences, inc.
27
Glaxosmithkline plc
15
Grupo aeroportuario del pacifico, s.a. de c.v.
12
Guardant health, inc.
12
Illumina, inc.
13
Immix biopharma, inc.
12
Incyte corporation
52
Jaguar health, inc.
16
Johnson & johnson
192
Kamada ltd.
15
Karyopharm therapeutics inc.
32
Lithium corp
15
Medtronic plc
35
Merck & company, inc.
51
Moderna, inc.
13
Morgan stanley
21
Nabors industries ltd.
19
Novartis ag
39
Novavax, inc.
15
Novo nordisk a/s
13
Orange
49
Perrigo company
62
Pfizer, inc.
57
Regeneron pharmaceuticals, inc.
69
Rigel pharmaceuticals, inc.
12
Sanofi
225
Takeda pharmaceutical company limited
34
Teva pharmaceutical industries ltd
27
Thermo fisher scientific inc
15
Vertex pharmaceuticals incorporated
12
Viatris inc.
11
Vision sensing acquisition corp.
16
Winnebago industries, inc.
13
Y-mabs therapeutics, inc.
21
Symbols
NVAX
15
TAK
1
Exchanges
Nasdaq
15
Nyse
1
Crawled Date
2023 - 10 - 31
1
2023 - 10 - 18
1
2023 - 01 - 18
1
2022 - 12 - 07
1
2022 - 08 - 18
1
2022 - 08 - 17
1
2022 - 08 - 12
1
2022 - 07 - 26
1
2022 - 04 - 19
1
2022 - 02 - 03
1
2022 - 01 - 12
1
2021 - 12 - 16
1
2021 - 11 - 15
1
2021 - 11 - 03
1
2021 - 10 - 29
1
Crawled Time
05:00
1
12:00
3
12:20
1
13:00
1
13:30
1
14:00
4
14:20
1
16:00
1
21:00
1
23:00
1
Source
www.biospace.com
9
www.prnewswire.com
6
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
approved
entities :
Novavax, inc.
save search
Novavax's Updated COVID-19 Vaccine Now Approved in the EU
Published:
2023-10-31
(Crawled : 21:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-41.59%
|
O:
0.6%
H:
5.22%
C:
4.48%
covid-19
vaccine
approved
Novavax's Prototype COVID-19 Vaccine Nuvaxovid™ Receives Full Approval in Singapore
Published:
2023-10-18
(Crawled : 13:30)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-39.69%
|
O:
-0.78%
H:
2.5%
C:
1.09%
covid-19
vaccine
prototype
approval
Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster
Published:
2023-01-18
(Crawled : 14:20)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-68.73%
|
O:
1.53%
H:
8.47%
C:
-1.19%
covid-19
vaccine
approved
nuvaxovid
Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Adolescents
Published:
2022-12-07
(Crawled : 16:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-76.82%
|
O:
0.0%
H:
6.02%
C:
2.62%
covid-19
vaccine
canada
approved
nuvaxovid
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand for Adolescents Aged 12 Through 17
Published:
2022-08-18
(Crawled : 14:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-90.12%
|
O:
0.97%
H:
0.0%
C:
-6.47%
covid-19
vaccine
granted
approval
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults
Published:
2022-08-17
(Crawled : 13:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-90.93%
|
O:
-1.82%
H:
1.31%
C:
-6.48%
covid-19
vaccine
granted
approval
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
Published:
2022-08-12
(Crawled : 14:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-90.36%
|
O:
2.03%
H:
4.62%
C:
0.75%
covid-19
vaccine
approved
Novavax Announces Expanded Approval of Nuvaxovid™ COVID-19 Vaccine for Adolescents Aged 12 through 17 in Japan
Published:
2022-07-26
(Crawled : 12:20)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-92.99%
|
O:
-0.2%
H:
6.0%
C:
2.08%
covid-19
japan
vaccine
approval
Novavax Announces Approval of Nuvaxovid™ COVID-19 Vaccine for Primary and Booster Immunization in Japan
Published:
2022-04-19
(Crawled : 12:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-93.39%
|
O:
-9.57%
H:
4.12%
C:
2.61%
covid-19
japan
vaccine
approval
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Published:
2022-02-03
(Crawled : 23:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-95.6%
|
O:
-0.2%
H:
3.78%
C:
1.16%
covid-19
approval
covid
vaccine
grant
granted
South Korea Ministry of Food and Drug Safety Approves Novavax COVID-19 Vaccine
Published:
2022-01-12
(Crawled : 12:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.1%
|
O:
-2.2%
H:
3.46%
C:
-0.75%
drug
vaccine
covid
food
Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published:
2021-12-16
(Crawled : 05:00)
- prnewswire.com
TAK
|
$13.15
-0.61%
0.0%
1.6M
|
Health Technology
|
-2.88%
|
O:
1.18%
H:
0.0%
C:
0.0%
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.71%
|
O:
5.55%
H:
0.0%
C:
0.0%
covid-19
new drug
application
drug
approval
covid
vaccine
submission
Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373
Published:
2021-11-15
(Crawled : 14:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.71%
|
O:
1.31%
H:
0.0%
C:
0.0%
application
license
approval
submission
nvx-cov2373
Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand
Published:
2021-11-03
(Crawled : 14:00)
- prnewswire.com
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.86%
|
O:
9.04%
H:
1.68%
C:
-1.49%
covid
vaccine
approval
covid-19
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia
Published:
2021-10-29
(Crawled : 12:00)
- biospace.com/
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-97.42%
|
O:
1.04%
H:
0.24%
C:
-2.2%
covid
australia
vaccine
approval
covid-19
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.